閉鎖系搬送デバイス市場：タイプ別（膜対膜、ニードルレス）、技術別（ダイアフラムベース、コンパートメント、フィルトレーション）、コンポーネント、エンドユーザー別（病院・診療所、オンコロジーセンター）、地域別 - 2026年までの世界予測

Closed System Transfer Devices Market by Type (Membrane-to-Membrane, Needleless), Technology (Diaphragm based, Compartmentalized, Filtration), Component, End User (Hospitals & Clinics, Oncology Centers), and Region - Global Forecast to 2026

閉鎖系移送装置（CSTD）市場は、2021年の8億1,400万米ドルから2026年には20億2,000万米ドルに達すると予測され、予測期間中のCAGRは19.7%となります。市場成長の主な要因は、細胞毒性薬剤の有害な影響（残効性... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2021年8月30日	US$4,950 シングルユーザライセンスライセンス・価格情報注文方法はこちら	230	228	英語

※ 調査会社の事情により、予告なしに価格が変更になる場合がございます。
最新の価格はデータリソースまでご確認ください。
日本語のページは自動翻訳を利用し作成しています。

サマリー

閉鎖系移送装置（CSTD）市場は、2021年の8億1,400万米ドルから2026年には20億2,000万米ドルに達すると予測され、予測期間中のCAGRは19.7%となります。市場成長の主な要因は、細胞毒性薬剤の有害な影響（残効性）、がんの発生率の上昇、がん治療薬の承認数の増加、危険な薬剤の安全な取り扱いに関する規制ガイドラインの改善などです。
"カラーツーカラー・アライメント・システムは、予測期間中に最も速い成長を遂げると予想される"

閉鎖メカニズムに基づいて、市場はルアーロックシステム、カラーツーカラーアライメントシステム、クリックトゥロックシステム、プッシュトゥターンシステムに分類されています。2020年には、ルアーロックシステムのセグメントが32.5%と最も高いシェアを占めています。このセグメントは、2021年の264.1百万米ドルから、2026年には636.8百万米ドルに達すると予想され、年平均成長率は19.2%となります。しかし、圧力均一化機構による高効率化と低コスト化により、色対色のアライメントシステム分野が最も高い成長率を示すと予想されています。

"予測期間において、メンブレン間システムが最も速い成長を遂げると予想されています。"

デバイスタイプに基づいて、市場はmembrane-to-membraneシステムとニードルレスシステムに分かれています。2020年のCSTD市場では、膜から膜へのシステムセグメントが71.01%と最大のシェアを占めています。このセグメントは、2021年の5億8,310万米ドルから、2026年には14億8,890万米ドルに達すると予想され、CAGRは20.6%です。このセグメントの大きなシェアと高い成長率は、二重膜式封じ込めシステムに関連する操作の容易さと汚染のリスクの低さに起因しています。

"ダイアフラムベースのデバイスセグメントは、2020年のクローズドシステムトランスファーデバイス市場で最大のシェアを占めています"

技術に基づいて、CSTD市場はダイアフラムベースのデバイス、コンパートメントデバイス、空気洗浄/ろ過デバイスに分類されます。2020年には、ダイヤフラムベースのデバイスセグメントが43.63%と最大のシェアを占めています。このセグメントは、2021年の3億5310万米ドルから、2026年には8億2940万米ドルに達すると予想され、年平均成長率は18.6%となります。このセグメントの大きなシェアは、主にこれらのデバイスが提供する操作の容易さと安全性によるものです。コンパートメント型機器は、低コストであることから、予測期間中に23.8%の最高CAGRで成長すると予想されています。

"2020年のクローズドシステムトランスファーデバイス市場では、バイアルアクセスデバイスセグメントが最大のシェアを占めています"

CSTD市場は、コンポーネントに基づいて、バイアルアクセスデバイス、シリンジセーフティデバイス、バッグ/ラインアクセスデバイス、およびアクセサリーに分類されます。2020年には、バイアルアクセスデバイスセグメントが33.08%と最大のシェアを占めています。このセグメントの大きなシェアは、主に腫瘍科の看護師がCSTD製品やバイアルアクセスデバイスを採用して、危険な薬剤をパッケージされたバイアルから輸液バッグや患者に移すことが増えていることによるものです。

"2020年の閉鎖系移送装置市場では、病院・診療所が最大のシェアを占める"

エンドユーザーに基づいて、市場は病院＆クリニック、腫瘍センター、その他のエンドユーザーに分類されています。2020年のCSTD市場では、病院＆クリニックが84.41%と最大のシェアを占めています。このセグメントの大きなシェアと高い成長は、高額なCSTDを購入するための病院の強い財政能力、大きながん患者プール、規制ガイドラインを遵守する必要性などが主な理由です。

"2020年の閉鎖系移送装置市場では、北米が最大のシェアを占める"

2020年には、北米が最大のシェアを占めました。北米市場の特徴は、先端技術へのアクセスが容易であること、腫瘍医、看護師、薬剤師の間でCSTDに関する認知度が高いこと、この地域に多くのCSTD製造プレイヤーが存在すること、がんの発生率や有病率が高いことなどです。しかし、APAC市場は、予測期間中に22.1%と最も高いCAGRを示すと予想されています。癌の発生率の上昇、発展途上国におけるより良い医療サービスへの需要の増加、国際的なプレーヤーがインドや中国などの新興市場に注目していることなどが、アジア太平洋市場の成長を後押ししています。

本レポートで言及している閉鎖系移送装置市場の主要参加企業（供給側）の内訳は以下の通りです。
- 企業タイプ別。ティア1-42%、ティア2-37%、ティア3-21%。
- 呼称別Cレベル：39％、ディレクターレベル：33％、その他：28
- 地域別地域別：北米-64%、欧州-17%、アジア太平洋-7%、ラテンアメリカ-6%、中東・アフリカ-6
閉鎖系移送装置市場の主要企業としては、Becton, Dickinson and Company（米国）、ICU Medical（米国）、B Braun Melsungen（ドイツ）、JMS（日本）、Equashield（米国）、Baxter International（米国）、West Pharmaceuticals Services（米国）、Simplivia Healthcare（イスラエル）、Corvida Medical（米国）。Yukon Medical（米国）、CODAN Medizinische Geräte GmbH & Co KG（ドイツ）、Victus（米国）、Caragen（アイルランド）、Vygon SA（米国）、Practivet（米国）、Corning Incorporated（米国）、Terumo Corporation（日本）、Cardinal Health（米国）、Eraser Medical（トルコ）、Insung Medical（韓国）などがあります。本調査では、クローズドシステム移送装置市場におけるこれらの主要プレイヤーの会社概要、最近の開発状況、主要な市場戦略とともに、詳細な競合分析を行っています。
調査範囲
この市場調査では、様々なセグメントにわたる閉鎖系移送装置市場をカバーしています。閉鎖メカニズム、タイプ、コンポーネント、技術、エンドユーザー、地域別の異なるセグメントにおけるこの市場のサイズと成長の可能性を推定することを目的としています。また、この調査では、市場の主要企業の詳細な競合分析に加え、企業プロフィール、製品や事業内容に関する重要な見解、最近の開発状況、主要な市場戦略などを紹介しています。
このレポートを購入する主なメリット
本レポートは、この市場のマーケットリーダー/新規参入者の助けとなり、クローズドシステムトランスファーデバイス市場とそのセグメントの最も近い近似値に関する情報を提供します。このレポートは、ステークホルダーが競争状況を理解し、ビジネスをより良く位置づけるための洞察を得て、適切な市場参入戦略を計画するのに役立ちます。また、本レポートは、ステークホルダーが市場の脈動を理解し、主要な市場推進要因、抑制要因、機会、および課題に関する情報を得るのに役立ちます。

ページTOPに戻る

Table of Contents

Summary

The closed system transfer devices (CSTDs) market is projected to reach USD 2,002 million by 2026 from USD 814 million in 2021, at a CAGR of 19.7% during the forecast period. Market growth is largely driven by the harmful effects (lingering role) of cytotoxic drugs, rising incidence of cancer, an increasing number of oncology drug approvals, and improving regulatory guidelines regarding the safe handling of hazardous drugs.
“Colour-to-colour alignment system is expected to witness the fastest growth in the forecast period.”

Based on the closing mechanism, the market is segmented into Luer-lock systems, color-to-color alignment systems, click-to-lock systems, and push-to-turn systems. In 2020, the Luer-lock systems segment accounted for the highest share of 32.5% of the market. This segment is expected to reach USD 636.8 million by 2026 from USD 264.1 million in 2021, at a CAGR of 19.2%. However, the color-to-color alignment systems segment is expected to grow at the highest rate because of its higher efficiency due to pressure equalization mechanisms and low cost.

“ Membrane-to-membrane systems is expected to witness the fastest growth in the forecast period.”

Based on device type, the market is segmented into membrane-to-membrane systems and needleless systems. In 2020, the membrane-to-membrane systems segment accounted for the largest share of 71.01% of the CSTDs market. This segment is expected to reach USD 1,488.9 million by 2026 from USD 583.1 million in 2021, at a CAGR of 20.6%. The large share and high growth of this segment are attributed to their ease of operation and lower risk of contamination associated with double-membrane containment systems.

“Diaphragm-based devices segment accounted for the largest share of closed system transfer devices market in 2020”

Based on technology, the CSTDs market is segmented into diaphragm-based devices, compartmentalized devices, and air cleaning/filtration devices. In 2020, the diaphragm-based devices segment accounted for the largest share of 43.63% of the market. This segment is expected to reach USD 829.4 million by 2026 from USD 353.1 million in 2021, at a CAGR of 18.6%. The large share of this segment is mainly due to the ease of operation and safety provided by these devices. The compartmentalized devices segment is expected to grow at the highest CAGR of 23.8% during the forecast period due to their lower cost.

“Vial access devices segment accounted for the largest share of closed system transfer devices market in 2020”

Based on components, the CSTDs market is segmented into vial access devices, syringe safety devices, bag/line access devices, and accessories. In 2020, the vial access devices segment accounted for the largest share of 33.08% of the market. The large share of this segment is mainly due to the increasing adoption of CSTD products and vial access devices by oncology nurses to transfer hazardous drugs from packaged vials to the infusion bag or the patient.

“Hospitals & Clinics accounted for the largest share of closed system transfer devices market in 2020”

Based on end users, the market is segmented into hospitals & clinics, oncology centers, and other end users. In 2020, hospitals & clinics accounted for the largest share of 84.41% of the CSTDs market. The large share and high growth of this segment are mainly due to the strong financial capabilities of hospitals for purchasing high-priced CSTDs, the large cancer patient pool, and the need to comply with regulatory guidelines.

“North America accounted for the largest share of the closed system transfer devices market in 2020”

In 2020, North America accounted for the largest share of the market. The market in North America is characterized by easy accessibility to advanced technologies, high awareness about CSTD among oncologists, nurses, and pharmacists, the presence of many CSTD manufacturing players in this region, and the high incidence and prevalence of cancer. However, the APAC market is expected to witness the highest CAGR of 22.1% during the forecast period. The rising incidence of cancer, increasing demand for better healthcare services in developing economies, and increasing focus of international players on emerging markets such as India and China drive the growth of the Asia Pacific market.

A breakdown of the primary participants (supply-side) for the closed system transfer devices market referred to for this report is provided below:
• By Company Type: Tier 1–42%, Tier 2–37%, and Tier 3–21%
• By Designation: C-level–39%, Director Level–33%, and Others–28%
• By Region: North America–64%, Europe–17%, Asia Pacific–7%, Latin America- 6%, and Middle East and Africa– 6%
Some of the key players in the closed system transfer device market are Becton, Dickinson and Company (US), ICU Medical (US), B Braun Melsungen (Germany), JMS (Japan), Equashield (US), Baxter International (US), West Pharmaceuticals Services (US), Simplivia Healthcare (Israel), Corvida Medical (US), Yukon Medical (US), CODAN Medizinische Geräte GmbH & Co KG (Germany), Victus (US), Caragen (Ireland), Vygon SA (US), Practivet (US), Corning Incorporated (US), Terumo Corporation (Japan), Cardinal Health (US), Eraser Medical (Turkey) and Insung Medical (South Korea) among others. The study includes an in-depth competitive analysis of these key players in the closed system transfer devices market, along with their company profiles, recent developments, and key market strategies.
Research Coverage:
The market study covers the closed system transfer devices market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by closing mechanism, type, component, technology, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the closed system transfer devices market and its segments. This report will help stakeholders understand the competitive landscape, gain insights to position their businesses better, and plan suitable go-to-market strategies. The report will also help stakeholders in understanding the pulse of the market and gaining information on key market drivers, restraints, opportunities, and challenges.

ページTOPに戻る

1 INTRODUCTION 30

1.1 OBJECTIVES OF THE STUDY 30

1.2 MARKET DEFINITION 30

1.2.1 INCLUSION AND EXCLUSIONS 30

1.3 MARKET SCOPE 31

FIGURE 1 CLOSED SYSTEM TRANSFER DEVICES MARKET SEGMENTATION 31

FIGURE 2 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY REGION 31

1.3.1 YEARS CONSIDERED FOR THE STUDY 32

1.4 CURRENCY 32

TABLE 1 STANDARD CURRENCY CONVERSION RATES 32

1.5 STAKEHOLDERS 33

2 RESEARCH METHODOLOGY 35

2.1 RESEARCH DATA 35

FIGURE 3 RESEARCH DESIGN 35

2.1.1 SECONDARY DATA 36

2.1.1.1 Key data from secondary sources 37

2.1.2 PRIMARY DATA 37

FIGURE 4 PRIMARY SOURCES 38

2.1.2.1 Key data from primary sources 39

2.1.2.2 Key industry insights 40

FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 40

FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY-SIDE):

BY COMPANY TYPE, DESIGNATION, AND REGION 41

FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND-SIDE):

BY END USER, DESIGNATION, AND REGION 41

2.2 MARKET SIZE ESTIMATION 42

FIGURE 8 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 42

FIGURE 9 REVENUE SHARE ANALYSIS ILLUSTRATION 42

FIGURE 10 REVENUE ANALYSIS OF THE TOP THREE PUBLIC COMPANIES: CLOSED SYSTEM TRANSFER DEVICES MARKET (2020) 43

FIGURE 11 BOTTOM-UP APPROACH 43

FIGURE 12 TOP-DOWN APPROACH 44

FIGURE 13 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE CLOSED SYSTEM TRANSFER DEVICES MARKET (2021–2026) 45

FIGURE 14 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 45

2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 46

FIGURE 15 DATA TRIANGULATION METHODOLOGY 46

2.4 ASSUMPTIONS FOR THE STUDY 47

2.5 LIMITATIONS 47

2.5.1 METHODOLOGY-RELATED LIMITATIONS 48

2.6 RISK ASSESSMENT 48

TABLE 2 RISK ASSESSMENT: CLOSED SYSTEM TRANSFER DEVICES MARKET 48

3 EXECUTIVE SUMMARY 49

FIGURE 16 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2021 VS. 2026 (USD MILLION) 49

FIGURE 17 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE,

2021 VS. 2026 (USD MILLION) 50

FIGURE 18 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY,

2021 VS. 2026 (USD MILLION) 50

FIGURE 19 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT,

2021 VS. 2026 (USD MILLION) 51

FIGURE 20 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER,

2021 VS. 2026 (USD MILLION) 52

FIGURE 21 GEOGRAPHIC SNAPSHOT: CLOSED SYSTEM TRANSFER DEVICES MARKET 53

4 PREMIUM INSIGHTS 54

4.1 CLOSED SYSTEM TRANSFER DEVICES MARKET OVERVIEW 54

FIGURE 22 THE RISING INCIDENCE OF CANCER IS DRIVING THE GROWTH OF

THE CLOSED SYSTEM TRANSFER DEVICES MARKET 54

4.2 ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET OVERVIEW 55

FIGURE 23 DIAPHRAGM-BASED DEVICES ACCOUNTED FOR THE LARGEST SHARE OF

THE APAC CLOSED SYSTEM TRANSFER DEVICES MARKET IN 2020 55

4.3 CLOSED SYSTEM TRANSFER DEVICES MARKET: REGIONAL MIX 56

FIGURE 24 NORTH AMERICA TO DOMINATE THE MARKET THROUGHOUT THE FORECAST PERIOD 56

4.4 CLOSED SYSTEM TRANSFER DEVICES MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56

FIGURE 25 CHINA TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 56

4.5 CLOSED SYSTEM TRANSFER DEVICES MARKET: DEVELOPING VS. DEVELOPED MARKETS 57

FIGURE 26 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING

THE FORECAST PERIOD 57

5 MARKET OVERVIEW 58

5.1 INTRODUCTION 58

FIGURE 27 CLOSED SYSTEM TRANSFER DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 58

5.1.1 DRIVERS 59

5.1.1.1 Rising incidence of cancer 59

FIGURE 28 GLOBAL CANCER INCIDENCE (2008–2030) 59

TABLE 3 CANCER RATES, BY COUNTRY (2018) 59

TABLE 4 US: NEW CANCER CASES (2017–2020) 60

5.1.1.2 The increasing number of oncology drug approvals 60

TABLE 5 FDA APPROVALS: NOVEL PRESCRIPTION CANCER DRUGS IN 2018 60

5.1.1.3 Increasing use of CSTDs to combat the harmful effects of cytotoxic or antineoplastic drugs 61

5.1.1.4 Growing emphasis on the implementation of occupational health and safety standards 62

TABLE 6 LIST OF NATIONAL/LOCAL REGULATORY BODIES RECOMMENDING THE USE OF CSTDS FOR THE SAFE HANDLING OF HAZARDOUS DRUGS, BY COUNTRY 63

5.1.2 RESTRAINTS 63

5.1.2.1 High cost of implementation of CSTDs and lack of reimbursement 63

TABLE 7 AVERAGE ANNUAL COSTS ASSOCIATED WITH THE IMPLEMENTATION OF VARIOUS CSTD SYSTEMS (USD) 64

5.1.2.2 Lack of compliance with regulatory guidelines in developing countries 64

5.1.3 OPPORTUNITIES 65

5.1.3.1 Increasing application of CSTDs in other therapeutic areas 65

5.1.3.2 Increasing adoption in emerging economies due to rising healthcare expenditure 65

5.1.4 CHALLENGES 66

5.1.4.1 Gaps with existing CSTDs 66

TABLE 8 ISSUES, CHALLENGES, AND POTENTIAL SOLUTIONS REGARDING THE SAFE HANDLING OF HAZARDOUS DRUGS 66

5.1.4.2 Low awareness among nurses about CSTDs 67

5.2 PORTER’S FIVE FORCES ANALYSIS 68

TABLE 9 CLOSED SYSTEM TRANSFER DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 68

5.2.1 THREAT OF NEW ENTRANTS 69

5.2.1.1 Growth in the medication delivery and management segment 69

5.2.1.2 Demand for safe drug compounding and handling devices 69

5.2.1.3 Highly concentrated market 69

5.2.1.4 Poor financing environment 69

5.2.1.5 Stringent regulatory environment 69

5.2.2 THREAT OF SUBSTITUTES 69

5.2.2.1 Unavailability of potential safe drug handling systems 69

5.2.2.2 Combination and integration of multiple technologies 70

5.2.3 BARGAINING POWER OF SUPPLIERS 70

5.2.3.1 Institutional technology providers 70

5.2.3.2 Substantially innovative technologies 70

5.2.3.3 Dysfunctional companies 70

5.2.4 BARGAINING POWER OF BUYERS 70

5.2.4.1 Few buyers and many sellers 70

5.2.4.2 Buy-out threat 70

5.2.4.3 Point of differentiation 70

5.2.5 INTENSITY OF COMPETITIVE RIVALRY 71

5.2.5.1 Highly concentrated industry 71

5.2.5.2 Similar funding source 71

5.3 INDUSTRY TRENDS 71

5.3.1 AUTOMATED COMPOUNDING OF HAZARDOUS DRUGS USING ROBOTIC SYSTEMS 71

5.3.2 EMERGING TECHNOLOGIES FOR RAPID DETECTION TESTS TO FACILITATE ROUTINE MONITORING AND SAFE HANDLING OF HAZARDOUS DRUGS 72

5.4 PRODUCT FEATURES AND PRICING ANALYSIS 72

TABLE 10 COMPARATIVE ANALYSIS OF COMMERCIALLY AVAILABLE CSTDS BASED ON PRODUCT FEATURES 73

5.5 UTILIZATION/ADOPTION OF CSTDS, BY REGION 74

TABLE 11 INTENSITY OF UTILIZATION/ADOPTION OF VARIOUS TYPES OF CSTDS,

BY REGION 74

5.6 REGULATORY GUIDELINES 75

TABLE 12 STRINGENCY OF REGULATIONS FOR THE ADOPTION OF CSTDS, BY REGION 75

5.6.1 USP <800> REGULATIONS 75

5.6.2 NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH 76

TABLE 13 NIOSH CLASSIFICATION OF HAZARDOUS DRUGS 76

TABLE 14 NIOSH HAZARDOUS DRUG ADMINISTRATION RECOMMENDATIONS AND <USP 800> REQUIREMENTS 77

5.6.3 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 78

TABLE 15 NIOSH AND ASHP DEFINITIONS OF HAZARDOUS DRUGS 78

5.6.4 INTERNATIONAL SOCIETY OF ONCOLOGY PHARMACY PRACTITIONERS 78

5.7 REGULATORY ANALYSIS 79

5.8 ECOSYSTEM MAPPING 79

FIGURE 29 CLOSED SYSTEM TRANSFER DEVICES MARKET: ECOSYSTEM (2020) 79

5.9 VALUE CHAIN ANALYSIS 80

FIGURE 30 VALUE CHAIN ANALYSIS: CLOSED SYSTEM TRANSFER DEVICES 80

5.10 SUPPLY CHAIN ANALYSIS 81

FIGURE 31 SUPPLY CHAIN ANALYSIS: CLOSED SYSTEM TRANSFER DEVICES MARKET 82

5.11 PATENT ANALYSIS 82

FIGURE 32 PATENT ANALYSIS: CLOSED SYSTEM TRANSFER DEVICES MARKET 82

5.12 KEY MARKETS FOR IMPORT AND EXPORT (TRADE ANALYSIS FOR CLOSED SYSTEM TRANSFER DEVICES) 83

TABLE 16 IMPORT VALUE OF CLOSED SYSTEM TRANSFER DEVICES FOR TOP 10 COUNTRIES IN 2020 83

5.13 COVID-19 IMPACT ANALYSIS 83

5.13.1 COVID-19 HEALTH ASSESSMENT 83

5.13.2 COVID-19 ECONOMIC ASSESSMENT 84

5.13.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 84

FIGURE 33 CRITERIA IMPACTING THE GLOBAL ECONOMY 84

5.13.4 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE CLOSED SYSTEM TRANSFER DEVICES MARKET 85

5.14 YC-YCC SHIFT 86

FIGURE 34 YC-YCC SHIFT IN THE CLOSED SYSTEM TRANSFER DEVICES MARKET 86

6 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM 87

6.1 INTRODUCTION 88

TABLE 17 TYPES OF CLOSING MECHANISMS IN THE CURRENTLY AVAILABLE CSTDS 88

TABLE 18 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019–2026 (USD MILLION) 88

6.2 LUER-LOCK SYSTEMS 89

6.2.1 LUER-LOCK MECHANISMS REDUCE THE RISK OF EXPOSURE, REQUIRE FEWER COMPONENTS, AND GENERATE LESS BIOHAZARDOUS WASTE—

KEY ADVANTAGES DRIVING GROWTH 89

TABLE 19 LUER-LOCK CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 89

6.3 PUSH-TO-TURN SYSTEMS 90

6.3.1 HIGH ADOPTION OF PHASEAL, A PIONEER IN THE CSTD MARKET—

A KEY MARKET DRIVER 90

TABLE 20 PUSH-TO-TURN CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 90

6.4 CLICK-TO-LOCK SYSTEMS 91

6.4.1 THE USER-FRIENDLY NATURE OF CLICK-TO-LOCK MECHANISMS DRIVES THEIR ADOPTION AMONG END USERS 91

TABLE 21 CLICK-TO-LOCK CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 91

6.5 COLOR-TO-COLOR ALIGNMENT SYSTEMS 92

6.5.1 LOW SYSTEM COST, ALONG WITH THE ADVANTAGES OFFERED, INCREASES THE ADOPTION OF THESE SYSTEMS AMONG PHARMACISTS, ONCOLOGISTS, AND NURSES 92

TABLE 22 COLOR-TO-COLOR ALIGNMENT CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 92

7 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE 93

7.1 INTRODUCTION 94

TABLE 23 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE,

2019–2026 (USD MILLION) 94

7.2 MEMBRANE-TO-MEMBRANE SYSTEMS 94

7.2.1 MEMBRANE-TO-MEMBRANE SYSTEMS PROVIDE A DOUBLE LAYER OF PROTECTION FOR THE SAFE TRANSFER OF HAZARDOUS DRUGS 94

TABLE 24 LEADING MANUFACTURERS OF MEMBRANE-TO-MEMBRANE SYSTEMS 94

TABLE 25 MEMBRANE-TO-MEMBRANE SYSTEMS MARKET, BY COUNTRY,

2019–2026 (USD MILLION) 95

7.3 NEEDLELESS SYSTEMS 95

7.3.1 CHEMOLOCK IS THE FIRST FDA-APPROVED NEEDLELESS CSTD SYSTEM 95

TABLE 26 LEADING MANUFACTURERS OF NEEDLELESS SYSTEMS 96

TABLE 27 NEEDLELESS SYSTEMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 96

8 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT 97

8.1 INTRODUCTION 98

TABLE 28 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT,

2019–2026 (USD MILLION) 98

8.2 VIAL ACCESS DEVICES 98

8.2.1 INCREASING REGULATORY COMPLIANCE TO DRIVE THE ADOPTION OF VIAL ACCESS DEVICES IN HOSPITALS & ONCOLOGY CENTERS 98

TABLE 29 VIAL ACCESS COMPONENTS FOR CLOSED SYSTEM TRANSFER DEVICES 99

TABLE 30 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR VIAL ACCESS DEVICES, BY COUNTRY, 2019–2026 (USD MILLION) 100

8.3 SYRINGE SAFETY DEVICES 100

8.3.1 ADVANTAGES SUCH AS EASE OF USE AND LEAK PREVENTION ARE DRIVING THE ADOPTION OF THESE DEVICES GLOBALLY 100

TABLE 31 SYRINGE SAFETY COMPONENTS FOR CLOSED SYSTEM TRANSFER DEVICES 101

TABLE 32 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR SYRINGE SAFETY DEVICES, BY COUNTRY, 2019–2026 (USD MILLION) 102

8.4 BAG/LINE ACCESS DEVICES 102

8.4.1 HIGH COMPATIBILITY OF BAG/LINE ACCESS DEVICES DRIVES MARKET GROWTH 102

TABLE 33 BAG/LINE ACCESS COMPONENTS FOR CLOSED SYSTEM TRANSFER DEVICES 103

TABLE 34 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR BAG/LINE ACCESS DEVICES, BY COUNTRY, 2019–2026 (USD MILLION) 104

8.5 ACCESSORIES 104

8.5.1 MAJOR CSTDS REQUIRE DEDICATED ADMINISTRATION SETS, WHICH DRIVES GROWTH IN THE ACCESSORIES MARKET 104

TABLE 35 ACCESSORIES FOR CLOSED SYSTEM TRANSFER DEVICES 105

TABLE 36 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR ACCESSORIES,

BY COUNTRY, 2019–2026 (USD MILLION) 106

9 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY 107

9.1 INTRODUCTION 108

TABLE 37 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY,

2019–2026 (USD MILLION) 108

9.2 DIAPHRAGM-BASED DEVICES 108

9.2.1 DIAPHRAGM-BASED DEVICES DOMINATE THE CLOSED SYSTEM TRANSFER DEVICES MARKET DUE TO THE EASE OF USE & SAFETY PROVIDED DURING THE HANDLING OF HAZARDOUS DRUGS 108

TABLE 38 DIAPHRAGM-BASED DEVICES AVAILABLE IN THE MARKET 108

TABLE 39 DIAPHRAGM-BASED CLOSED SYSTEM TRANSFER DEVICES MARKET,

BY COUNTRY, 2019–2026 (USD MILLION) 109

9.3 COMPARTMENTALIZED DEVICES 109

9.3.1 COMPARTMENTALIZED DEVICES TO WITNESS THE HIGHEST GROWTH IN

THE MARKET DURING THE FORECAST PERIOD 109

TABLE 40 COMPARTMENTALIZED DEVICES AVAILABLE IN THE MARKET 110

TABLE 41 COMPARTMENTALIZED CLOSED SYSTEM TRANSFER DEVICES MARKET,

BY COUNTRY, 2019–2026 (USD MILLION) 110

9.4 AIR CLEANING/FILTRATION DEVICES 111

9.4.1 AIR CLEANING DEVICES INCORPORATE AN ACTIVATED CARBON OR HYDROPHOBIC FILTER TO HELP REDUCE THE OUTFLOW OF CONTAMINANTS 111

TABLE 42 AIR CLEANING/FILTRATION DEVICES AVAILABLE IN THE MARKET 111

TABLE 43 AIR CLEANING/FILTRATION CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 111

10 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER 112

10.1 INTRODUCTION 113

TABLE 44 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER,

2019–2026 (USD MILLION) 113

10.2 HOSPITALS & CLINICS 113

10.2.1 HOSPITALS FORM THE LARGEST END-USER SEGMENT OF THE CLOSED SYSTEM TRANSFER DEVICES MARKET 113

TABLE 45 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2019–2026 (USD MILLION) 114

10.3 ONCOLOGY CENTERS 114

10.3.1 INCREASING REGULATORY MANDATES TO DRIVE THE ADOPTION OF CSTDS IN ONCOLOGY CENTERS & CLINICS 114

TABLE 46 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR ONCOLOGY CENTERS,

BY COUNTRY, 2019–2026 (USD MILLION) 115

10.4 OTHER END USERS 115

TABLE 47 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR OTHER END USERS,

BY COUNTRY, 2019–2026 (USD MILLION) 116

11 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY REGION 117

11.1 INTRODUCTION 118

FIGURE 35 CLOSED SYSTEM TRANSFER DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 118

TABLE 48 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY REGION,

2019–2026 (USD MILLION) 119

11.2 NORTH AMERICA 120

FIGURE 36 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET SNAPSHOT 120

TABLE 49 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET,

BY COUNTRY, 2019–2026 (USD MILLION) 121

TABLE 50 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET,

BY CLOSING MECHANISM, 2019–2026 (USD MILLION) 121

TABLE 51 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET,

BY TYPE, 2019–2026 (USD MILLION) 121

TABLE 52 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET,

BY COMPONENT, 2019–2026 (USD MILLION) 122

TABLE 53 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET,

BY TECHNOLOGY, 2019–2026 (USD MILLION) 122

TABLE 54 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET,

BY END USER, 2019–2026 (USD MILLION) 122

11.2.1 US 123

11.2.1.1 US dominates the North American market primarily due to the presence of leading CSTD manufacturing companies & the high burden of cancer 123

TABLE 55 US: KEY MACROINDICATORS 124

TABLE 56 US: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019–2026 (USD MILLION) 124

TABLE 57 US: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE,

2019–2026 (USD MILLION) 124

TABLE 58 US: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT,

2019–2026 (USD MILLION) 125

TABLE 59 US: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY,

2019–2026 (USD MILLION) 125

TABLE 60 US: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER,

2019–2026 (USD MILLION) 125

11.2.2 CANADA 126

11.2.2.1 Increasing prevalence of cancer to drive the growth of the Canadian market 126

TABLE 61 CANADA: KEY MACROINDICATORS 126

TABLE 62 CANADA: CLOSED SYSTEM TRANSFER DEVICES MARKET,

BY CLOSING MECHANISM, 2019–2026 (USD MILLION) 127

TABLE 63 CANADA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE,

2019–2026 (USD MILLION) 127

TABLE 64 CANADA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019–2026 (USD MILLION) 127

TABLE 65 CANADA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 128

TABLE 66 CANADA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION) 128

11.3 EUROPE 128

FIGURE 37 EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET SNAPSHOT 129

TABLE 67 EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 130

TABLE 68 EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET,

BY CLOSING MECHANISM, 2019–2026 (USD MILLION) 130

TABLE 69 EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE,

2019–2026 (USD MILLION) 130

TABLE 70 EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019–2026 (USD MILLION) 131

TABLE 71 EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 131

TABLE 72 EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION) 131

11.3.1 GERMANY 132

11.3.1.1 Germany to witness the highest growth in the European market 132

TABLE 73 GERMANY: KEY MACROINDICATORS 132

TABLE 74 GERMANY: CLOSED SYSTEM TRANSFER DEVICES MARKET,

BY CLOSING MECHANISM, 2019–2026 (USD MILLION) 133

TABLE 75 GERMANY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE,

2019–2026 (USD MILLION) 133

TABLE 76 GERMANY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019–2026 (USD MILLION) 133

TABLE 77 GERMANY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 134

TABLE 78 GERMANY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION) 134

11.3.2 UK 134

11.3.2.1 High cost of CSTDs to restrain the market growth 134

TABLE 79 UK: KEY MACROINDICATORS 135

TABLE 80 UK: CLOSED SYSTEM TRANSFER DEVICES MARKET,

BY CLOSING MECHANISM, 2019–2026 (USD MILLION) 135

TABLE 81 UK: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE,

2019–2026 (USD MILLION) 135

TABLE 82 UK: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT,

2019–2026 (USD MILLION) 136

TABLE 83 UK: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY,

2019–2026 (USD MILLION) 136

TABLE 84 UK: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER,

2019–2026 (USD MILLION) 136

11.3.3 FRANCE 137

11.3.3.1 High cancer prevalence and the high healthcare expenditure in

the country to drive market growth in France 137

TABLE 85 FRANCE: KEY MACROINDICATORS 137

TABLE 86 FRANCE: CLOSED SYSTEM TRANSFER DEVICES MARKET,

BY CLOSING MECHANISM, 2019–2026 (USD MILLION) 137

TABLE 87 FRANCE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE,

2019–2026 (USD MILLION) 138

TABLE 88 FRANCE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019–2026 (USD MILLION) 138

TABLE 89 FRANCE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 138

TABLE 90 FRANCE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION) 139

11.3.4 ITALY 139

11.3.4.1 Increasing geriatric population and the subsequent increase in the prevalence of cancer to drive the market for closed system transfer devices in Italy 139

TABLE 91 ITALY: KEY MACROINDICATORS 140

TABLE 92 ITALY: CLOSED SYSTEM TRANSFER DEVICES MARKET,

BY CLOSING MECHANISM, 2019–2026 (USD MILLION) 140

TABLE 93 ITALY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE,

2019–2026 (USD MILLION) 140

TABLE 94 ITALY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019–2026 (USD MILLION) 141

TABLE 95 ITALY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 141

TABLE 96 ITALY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER,

2019–2026 (USD MILLION) 141

11.3.5 SPAIN 142

11.3.5.1 Lack of specific regulations about CSTDs is restraining the growth of this market 142

TABLE 97 SPAIN: KEY MACROINDICATORS 142

TABLE 98 SPAIN: CLOSED SYSTEM TRANSFER DEVICES MARKET,

BY CLOSING MECHANISM, 2019–2026 (USD MILLION) 142

TABLE 99 SPAIN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE,

2019–2026 (USD MILLION) 143

TABLE 100 SPAIN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019–2026 (USD MILLION) 143

TABLE 101 SPAIN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 143

TABLE 102 SPAIN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER,

2019–2026 (USD MILLION) 144

11.3.6 REST OF EUROPE 144

TABLE 103 ROE: CLOSED SYSTEM TRANSFER DEVICES MARKET,

BY CLOSING MECHANISM, 2019–2026 (USD MILLION) 145

TABLE 104 ROE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE,

2019–2026 (USD MILLION) 145

TABLE 105 ROE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019–2026 (USD MILLION) 145

TABLE 106 ROE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 146

TABLE 107 ROE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER,

2019–2026 (USD MILLION) 146

11.4 ASIA PACIFIC 146

FIGURE 38 ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET SNAPSHOT 147

TABLE 108 APAC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY,

2019–2026 (USD MILLION) 148

TABLE 109 APAC: CLOSED SYSTEM TRANSFER DEVICES MARKET,

BY CLOSING MECHANISM, 2019–2026 (USD MILLION) 148

TABLE 110 APAC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE,

2019–2026 (USD MILLION) 148

TABLE 111 APAC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019–2026 (USD MILLION) 149

TABLE 112 APAC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 149

TABLE 113 APAC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER,

2019–2026 (USD MILLION) 149

11.4.1 JAPAN 150

11.4.1.1 Japan to dominate the APAC CSTDs market 150

TABLE 114 JAPAN: KEY MACROINDICATORS 151

TABLE 115 JAPAN: CLOSED SYSTEM TRANSFER DEVICES MARKET,

BY CLOSING MECHANISM, 2019–2026 (USD MILLION) 151

TABLE 116 JAPAN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE,

2019–2026 (USD MILLION) 151

TABLE 117 JAPAN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019–2026 (USD MILLION) 152

TABLE 118 JAPAN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 152

TABLE 119 JAPAN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER,

2019–2026 (USD MILLION) 152

11.4.2 CHINA 153

11.4.2.1 The large patient pool provides significant growth opportunities

in China 153

TABLE 120 CHINA: KEY MACROINDICATORS 153

TABLE 121 CHINA: CLOSED SYSTEM TRANSFER DEVICES MARKET,

BY CLOSING MECHANISM, 2019–2026 (USD MILLION) 154

TABLE 122 CHINA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE,

2019–2026 (USD MILLION) 154

TABLE 123 CHINA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019–2026 (USD MILLION) 154

TABLE 124 CHINA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 155

TABLE 125 CHINA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER,

2019–2026 (USD MILLION) 155

11.4.3 INDIA 155

11.4.3.1 Low manufacturing costs and skilled workforce are attracting outsourcing and investment to India 155

TABLE 126 INDIA: KEY MACROINDICATORS 156

TABLE 127 INDIA: CLOSED SYSTEM TRANSFER DEVICES MARKET,

BY CLOSING MECHANISM, 2019–2026 (USD MILLION) 156

TABLE 128 INDIA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE,

2019–2026 (USD MILLION) 156

TABLE 129 INDIA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019–2026 (USD MILLION) 157

TABLE 130 INDIA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 157

TABLE 131 INDIA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER,

2019–2026 (USD MILLION) 157

11.4.4 REST OF APAC 158

TABLE 132 ROAPAC: CLOSED SYSTEM TRANSFER DEVICES MARKET,

BY CLOSING MECHANISM, 2019–2026 (USD MILLION) 158

TABLE 133 ROAPAC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE,

2019–2026 (USD MILLION) 158

TABLE 134 ROAPAC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019–2026 (USD MILLION) 159

TABLE 135 ROAPAC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 159

TABLE 136 ROAPAC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION) 159

11.5 LATIN AMERICA 160

11.5.1 RISING CANCER INCIDENCE TO DRIVE MARKET GROWTH IN LATAM 160

TABLE 137 LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET,

BY CLOSING MECHANISM, 2019–2026 (USD MILLION) 160

TABLE 138 LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET,

BY TYPE, 2019–2026 (USD MILLION) 160

TABLE 139 LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET,

BY COMPONENT, 2019–2026 (USD MILLION) 161

TABLE 140 LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET,

BY TECHNOLOGY, 2019–2026 (USD MILLION) 161

TABLE 141 LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET,

BY END USER, 2019–2026 (USD MILLION) 161

11.6 MIDDLE EAST AND AFRICA 162

11.6.1 MEA MARKET TO GROW AT A SLOWER RATE THAN LATIN AMERICA 162

TABLE 142 MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET,

BY CLOSING MECHANISM, 2019–2026 (USD MILLION) 162

TABLE 143 MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET,

BY TYPE, 2019–2026 (USD MILLION) 162

TABLE 144 MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET,

BY COMPONENT, 2019–2026 (USD MILLION) 163

TABLE 145 MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET,

BY TECHNOLOGY, 2019–2026 (USD MILLION) 163

TABLE 146 MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET,

BY END USER, 2019–2026 (USD MILLION) 163

12 COMPETITIVE LANDSCAPE 164

12.1 OVERVIEW 164

12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 164

FIGURE 39 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE CLOSED SYSTEM TRANSFER DEVICE MARKET 165

12.3 REVENUE SHARE ANALYSIS 166

12.3.1 REVENUE ANALYSIS FOR KEY PLAYERS IN THE CLOSED SYSTEM TRANSFER DEVICES MARKET 166

FIGURE 40 REVENUE ANALYSIS FOR KEY PLAYERS IN THE CLOSED SYSTEM TRANSFER DEVICES MARKET IN THE PAST FIVE YEARS 166

12.4 MARKET SHARE ANALYSIS 167

12.4.1 CLOSED SYSTEM TRANSFER DEVICES MARKET (2020) 167

FIGURE 41 SHARE OF LEADING COMPANIES IN THE GLOBAL CLOSED SYSTEM TRANSFER DEVICES MARKET (2020) 167

TABLE 147 CLOSED SYSTEM TRANSFER DEVICES MARKET: DEGREE OF COMPETITION 168

12.5 R&D ASSESSMENT OF KEY PLAYERS 168

12.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 169

12.7 COMPANY EVALUATION QUADRANT 170

12.7.1 COMPANY EVALUATION QUADRANT: CLOSED SYSTEM TRANSFER DEVICES MARKET 170

12.7.1.1 Stars 170

12.7.1.2 Pervasive players 170

12.7.1.3 Emerging leaders 170

12.7.1.4 Participants 170

FIGURE 42 CLOSED SYSTEM TRANSFER DEVICES MARKET: COMPANY EVALUATION MATRIX, 2020 171

12.8 COMPETITIVE BENCHMARKING 172

12.8.1 OVERALL COMPANY FOOTPRINT 172

TABLE 148 OVERALL COMPANY FOOTPRINT (20 COMPANIES) 172

TABLE 149 COMPANY FOOTPRINT: BY CLOSING MECHANISM (20 COMPANIES) 173

TABLE 150 COMPANY FOOTPRINT: BY TYPE (20 COMPANIES) 174

TABLE 151 COMPANY FOOTPRINT: BY COMPONENT (20 COMPANIES) 175

TABLE 152 COMPANY FOOTPRINT: BY TECHNOLOGY (20 COMPANIES) 176

TABLE 153 COMPANY FOOTPRINT: BY END USER (20 COMPANIES) 177

TABLE 154 COMPANY FOOTPRINT: BY REGION (20 COMPANIES) 178

12.9 COMPETITIVE SITUATIONS AND TRENDS 179

12.9.1 PRODUCT LAUNCHES & APPROVALS 179

TABLE 155 PRODUCT LAUNCHES & APPROVALS (2018–MAY 2021) 179

12.9.2 DEALS 179

TABLE 156 DEALS (2018–MAY 2021) 179

12.9.3 OTHER DEVELOPMENTS 180

TABLE 157 OTHER DEVELOPMENTS (2018–MAY 2021) 180

13 COMPANY PROFILES 181

13.1 KEY PLAYERS 181

(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*

13.1.1 BECTON, DICKINSON AND COMPANY 181

TABLE 158 BD: BUSINESS OVERVIEW 181

FIGURE 43 BD: COMPANY SNAPSHOT 182

13.1.2 ICU MEDICAL 185

TABLE 159 ICU MEDICAL: BUSINESS OVERVIEW 185

FIGURE 44 ICU MEDICAL: COMPANY SNAPSHOT 186

13.1.3 EQUASHIELD 189

TABLE 160 EQUASHIELD: BUSINESS OVERVIEW 189

13.1.4 B. BRAUN MELSUNGEN 192

TABLE 161 B. BRAUN MELSUNGEN: BUSINESS OVERVIEW 192

FIGURE 45 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT 193

13.1.5 JMS 195

TABLE 162 JMS: BUSINESS OVERVIEW 195

FIGURE 46 JMS: COMPANY SNAPSHOT 195

13.1.6 BAXTER INTERNATIONAL 197

TABLE 163 BAXTER INTERNATIONAL.: BUSINESS OVERVIEW 197

FIGURE 47 BAXTER INTERNATIONAL: COMPANY SNAPSHOT 198

13.1.7 SIMPLIVIA HEALTHCARE 200

TABLE 164 SIMPLIVIA HEALTHCARE: BUSINESS OVERVIEW 200

13.1.8 CORVIDA MEDICAL 202

TABLE 165 CORVIDA MEDICAL: BUSINESS OVERVIEW 202

13.1.9 YUKON MEDICAL 203

TABLE 166 YUKON MEDICAL: BUSINESS OVERVIEW 203

13.1.10 CODAN MEDIZINISCHE GERÄTE 205

TABLE 167 CODAN MEDIZINISCHE GERÄTE: BUSINESS OVERVIEW 205

13.1.11 VICTUS 207

TABLE 168 VICTUS: BUSINESS OVERVIEW 207

13.1.12 CARAGEN 208

TABLE 169 CARAGEN: BUSINESS OVERVIEW 208

13.2 OTHER PLAYERS 209

13.2.1 WEST PHARMACEUTICALS SERVICES 209

TABLE 170 WEST PHARMACEUTICALS SERVICES: BUSINESS OVERVIEW 209

FIGURE 48 WEST PHARMACEUTICAL SERVICES: COMPANY SNAPSHOT (2020) 210

13.2.2 VYGON SA 212

TABLE 171 VYGON: BUSINESS OVERVIEW 212

13.2.3 PRACTIVET 213

TABLE 172 PRACTIVET: BUSINESS OVERVIEW 213

13.2.4 CORNING INCORPORATED 214

TABLE 173 CORNING INCORPORATED: BUSINESS OVERVIEW 214

FIGURE 49 CORNING INCORPORATED: COMPANY SNAPSHOT (2020) 215

13.2.5 TERUMO CORPORATION 216

TABLE 174 TERUMO CORPORATION: BUSINESS OVERVIEW 216

FIGURE 50 TERUMO CORPORATION: COMPANY SNAPSHOT 217

13.2.6 CARDINAL HEALTH 219

TABLE 175 CARDINAL HEALTH: BUSINESS OVERVIEW 219

FIGURE 51 CARDINAL HEALTH: COMPANY SNAPSHOT 220

13.2.7 ERASER MEDICAL 222

TABLE 176 ERASER MEDICAL: BUSINESS OVERVIEW 222

13.2.8 INSUNG MEDICAL 223

TABLE 177 INSUNG MEDICAL: BUSINESS OVERVIEW 223

13.2.9 NEEDLELESS CORPORATION 224

13.2.10 ADVCARE MEDICAL 225

13.2.11 ELCAM MEDICAL 226

13.2.12 EPIC MEDICAL 227

13.2.13 EDGE PHARMA 228

*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.

14 APPENDIX 229

14.1 DISCUSSION GUIDE 229

14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 233

14.3 AVAILABLE CUSTOMIZATIONS 235

14.4 RELATED REPORTS 235

14.5 AUTHOR DETAILS 236

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

本レポートと同分野の最新刊レポートはありません。

MarketsandMarkets社の分野での最新刊レポート

最新刊レポートはありません。

本レポートと同じKEY WORD（）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野の最新刊レポート

MarketsandMarkets社の分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?